The FDA is getting a lot more aggressive about fighting the opioid crisis (ENDP)

Reuters For the first time, the FDA has asked a drug company to remove its opioid painkiller off the market. The FDA requested on Thursday that Endo International take its extended-release opioid painkiller Opana ER (otherwise known as oxymorphone hydrochloride) off the market, after deciding thatthe drug's benefits no longer outweighed its risk for abuse. The FDA rarely asks drugmakers to remove products from the market, and this is the first time it's asked for an opioid to be removed for a pu...